| Waste minimized synthesis of pharmaceutically active compounds via heterogeneous manganese catalysed C–H oxidation in flow F Ferlin, PML Navarro, Y Gu, D Lanari, L Vaccaro Green chemistry 22 (2), 397-403, 2020 | 44 | 2020 |
| EB-3D a novel choline kinase inhibitor induces deregulation of the AMPK-mTOR pathway and apoptosis in leukemia T-cells E Mariotto, R Bortolozzi, I Volpin, D Carta, V Serafin, B Accordi, G Basso, ... Biochemical Pharmacology 155, 213-223, 2018 | 25 | 2018 |
| A solvatofluorochromic silicon-substituted xanthene dye useful in bioimaging L Espinar-Barranco, P Luque-Navarro, MA Strnad, P Herrero-Foncubierta, ... Dyes and Pigments 168, 264-272, 2019 | 11 | 2019 |
| Flow synthesis of biologically-relevant compound libraries PM Luque Navarro, D Lanari Molecules 25 (4), 909, 2020 | 7 | 2020 |
| Anticancer and structure activity relationship of non-symmetrical choline kinase inhibitors S Schiaffino-Ortega, E Mariotto, PM Luque-Navarro, M Kimatrai-Salvador, ... Pharmaceutics 13 (9), 1360, 2021 | 5 | 2021 |
| New bioisosteric sulphur-containing choline kinase inhibitors with a tracked mode of action PM Luque-Navarro, MP Carrasco-Jiménez, L Goracci, JM Paredes, ... European Journal of Medicinal Chemistry, 115003, 2022 | 3 | 2022 |
| Anticancer activity of the choline kinase inhibitor PL48 is due to selective disruption of choline metabolism and transport systems in cancer cell lines P García-Molina, A Sola-Leyva, PM Luque-Navarro, A Laso, ... Pharmaceutics 14 (2), 426, 2022 | 3 | 2022 |
| New Compounds with Bioisosteric Replacement of Classic Choline Kinase Inhibitors Show Potent Antiplasmodial Activity FJ Aguilar-Troyano, A Torretta, G Rubbini, A Fasiolo, PM Luque-Navarro, ... Pharmaceutics 13 (11), 1842, 2021 | 3 | 2021 |
| Biological evaluation of new thienopyridinium and thienopyrimidinium derivatives as human choline kinase inhibitors PM Luque-Navarro, E Mariotto, M Ballarotto, G Rubbini, ... Pharmaceutics 14 (4), 715, 2022 | 2 | 2022 |
| Biological Evaluation of New Thienopyridinium and Thienopyrimidinium Derivatives as Human Choline Kinase Inhibitors. Pharmaceutics 2022, 14, 715 PM Luque-Navarro, E Mariotto, M Ballarotto, G Rubbini, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | | 2022 |
| Sustainable synthesis of biologically active molecules PM Luque Navarro Universidad de Granada, 2022 | | 2022 |
